FARMINGTON, Conn., Aug. 6, 2019 /PRNewswire-PRWeb/ -- Shoreline Biome, a microbiome research company that develops
The distributors will sell Shoreline Biome's microbiome kits and other products to companies and research organizations in Australia, Benelux, Indonesia, Korea, Malaysia, Myanmar, New Zealand, Singapore, the United Kingdom, and Vietnam.
"These distribution agreements, and others that are pending, enable researchers outside the U.S. to access our transformative tools and technologies," said Bill McKenzie, Shoreline Biome's CEO. "Our all-in-one kits and software accelerate breakthroughs in microbiome research, ultimately leading to a better understanding of how our microbiomes relate to human health and disease."
Shoreline Biome's international distributors include the following:
Additional agreements with distributors in the Nordic region, Japan, and China are pending.
A detailed list of Shoreline Biome's international distributors and ordering information by country can be accessed at shorelinebiome.com/international-distributors.
About Shoreline Biome: Characterizing the human microbiome and analyzing its role in human health and disease are priority goals for researchers around the world. Shoreline Biome accelerates breakthroughs in microbiome research by developing transformative discovery tools that characterize microbiome populations down to the strain level. With Shoreline Biome products, all it takes is three easy steps: lyse, purify, and amplify. Shoreline Biome's easy-to-use companion analysis software and comprehensive reference database enables straightforward strain-level identification and quantitation of all bacteria in the sample. To learn more, visit shorelinebiome.com.
SOURCE Shoreline Biome
Subscribe to our Free Newsletters!